Abstract:Purpose To retrospectively evaluate the safety and efficacy of percutaneous computed tomography (CT)-guided microwave ablation (MWA) in colorectal cancer (CRC) lung metastases, and to analyze prognostic factors. Materials and methods Data were collected from 31 patients with CRC lung metastases from May 2013 to September 2017. They had removed the CRC, no extrapulmonary metastases, no more than three metastases in the lung, the maximum diameter of the lesions was ≤3 cm, and all the lung metastases could be completely ablated. The ablation procedures were performed using a KY-2000 microwave multifunctional therapeutic apparatus. Efficacy is assessed two to four weeks after ablation, and follow-up are performed every three months for two years. The primary outcome was overall survival (OS). The secondary outcomes were progression-free survival (PFS), and complications. Cox regression analysis was used for the evaluation of the statistical significance of factors affecting the end result of MWA therapy. The Kaplan–Meier method was used for estimation of survival rates. Results A total of 45 metastatic lung lesions from CRC in 31 patients were treated with CT-guided MWA procedures. The median OS was 76 months. The one, two, three, and five-year survival rates were 93.5%, 80.6%, 61.3%, and 51.6%, respectively. Multivariate analysis showed that the primary tumor from the rectum ( P = 0.009) and liver metastases at the diagnosis of lung metastases ( P = 0.043) were risk factors affecting OS, while PFS was a protective factor. The median PFS was 13 months. The maximum diameter of lung metastases lesions ( P = 0.004) was a risk factor. The interval between pulmonary metastases and MWA ( P =0.031) was the protective factor. Pneumothorax was observed in 13 out of 36 procedures. Four patients developed pneumothorax requiring drainage tube insertion. No patient deaths occurred within 30 days of ablation. Three out of 31 patients (9.67%) were found to have local recurrence of the original lung metastatic ablation foci. Conclusion MWA therapy may be safely and effectively used as a therapeutic tool for the treatment of selected CRC pulmonary metastases, and the prognosis is better in patients without liver metastases at the diagnosis of lung metastases.

Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study

Evaluating the Efficacy and Safety of Ultrasound-Guided Percutaneous Microwave Ablation for the Treatment of Adrenal Metastasis

Percutaneous Microwave Ablation of Adrenal Tumours under Ultrasound Guidance in 33 Patients with 35 Tumours: A Single-Centre Experience

Ultrasound-guided Percutaneous Microwave Ablation of Adrenal Metastasis: Preliminary Results

A Study of Ultrasound-Guided Percutaneous Microwave Ablation of Adrenal Tumor

Ultrasound-guided Percutaneous Microwave Ablation Assisted by a Three-Dimensional Visualization Preoperative Treatment Planning System for Larger Adrenal Metastasis (D ≥ 4 Cm): Preliminary Results

CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results.

Clinical Outcome of Ultrasound-Guided Percutaneous Microwave Ablation on Colorectal Liver Metastases.

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

Effect of Ultrasound-Guided Percutaneous Cooled-Tip Microwave Ablation on Adrenal Tumor:A Primary Analysis

Ultrasound guided percutaneous microwave ablation treatment for renal carcinomas at T1a stage: the safety evaluation in clinical application

Percutaneous ablation for adrenal metastasis from non-small-cell lung cancer: comparison between cryoablation and microwave ablation

Long-term outcome following microwave ablation of lung metastases from colorectal cancer

CT-guided Percutaneous Microwave Ablation of Pulmonary Malignancies: Results in 69 Cases

Complications of Ultrasound-Guided Percutaneous Microwave Ablation of Renal Cell Carcinoma.

The Safety And Efficacy Of Microwave Ablation For The Treatment Of Crc Pulmonary Metastases

Us-Guided Percutaneous Microwave Ablation of Renal Cell Carcinoma: Intermediate-Term Results

Percutaneous Microwave Ablation of Renal Cell Carcinoma is Safe in Patients with a Solitary Kidney

[Clinical Evaluation of Ultrasound-Guided Percutaneous Microwave Ablation of Splenic Tumors].

CT‐guided Microwave Ablation in Patients with Lung Metastases from Breast Cancer

Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results.